Trial · NCT01254864
Adverse events580
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 580
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal Pain | Gastrointestinal disorders | Abiraterone Acetate + Prednisone (AP) | 0 | 179 | |
| other | Abdominal Pain | Gastrointestinal disorders | AP + Sunitinib | 3 | 64 | |
| other | Abdominal Pain | Gastrointestinal disorders | AP + Sunitinib → AP + Dasatanib | 0 | 39 | |
| other | Abdominal Pain | Gastrointestinal disorders | AP + Dasatinib | 4 | 68 | |
| other | Abdominal Pain | Gastrointestinal disorders | AP + Dasatanib → AP + Sunitinib | 2 | 32 | |
| other | Activated Partial Thromboplastin Time Prolonged | Investigations | Abiraterone Acetate + Prednisone (AP) | 0 | 179 | |
| other | Activated Partial Thromboplastin Time Prolonged | Investigations | AP + Sunitinib | 0 | 64 | |
| other | Activated Partial Thromboplastin Time Prolonged | Investigations | AP + Sunitinib → AP + Dasatanib | 2 | 39 | |
| other | Activated Partial Thromboplastin Time Prolonged | Investigations | AP + Dasatinib | 0 | 68 | |
| other | Activated Partial Thromboplastin Time Prolonged | Investigations | AP + Dasatanib → AP + Sunitinib | 0 | 32 | |
| other | Alanine Aminotransferase Increased | Investigations | Abiraterone Acetate + Prednisone (AP) | 11 | 179 | |
| other | Alanine Aminotransferase Increased | Investigations | AP + Sunitinib | 9 | 64 | |
| other | Alanine Aminotransferase Increased | Investigations | AP + Sunitinib → AP + Dasatanib | 10 | 39 | |
| other | Alanine Aminotransferase Increased | Investigations | AP + Dasatinib | 12 | 68 | |
| other | Alanine Aminotransferase Increased | Investigations | AP + Dasatanib → AP + Sunitinib | 7 | 32 | |
| other | Alkaline Phosphatase Increased | Investigations | Abiraterone Acetate + Prednisone (AP) | 23 | 179 | |
| other | Alkaline Phosphatase Increased | Investigations | AP + Sunitinib | 16 | 64 | |
| other | Alkaline Phosphatase Increased | Investigations | AP + Sunitinib → AP + Dasatanib | 22 | 39 | |
| other | Alkaline Phosphatase Increased | Investigations | AP + Dasatinib | 24 | 68 | |
| other | Alkaline Phosphatase Increased | Investigations | AP + Dasatanib → AP + Sunitinib | 15 | 32 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01254864/events